Menu Close

Author: WorkCompAcademy

Study Claims Fewer Painkillers Prescribed in 17 Medical Marijuana States

Legalization of medical marijuana has been one of the most controversial areas of state policy change over the past twenty years. However, little is known about whether medical marijuana is being used clinically to any significant degree.

A new study, released in the journal Health Affairs and summarized in the Washington Post found that, in the 17 states with a medical-marijuana law in place by 2013, prescriptions for painkillers and other classes of drugs fell sharply compared with states that did not have a medical-marijuana law. The drops were quite significant: In medical-marijuana states, the average doctor prescribed 265 fewer doses of antidepressants each year, 486 fewer doses of seizure medication, 541 fewer anti-nausea doses and 562 fewer doses of anti-anxiety medication.

But most strikingly, the typical physician in a medical-marijuana state prescribed 1,826 fewer doses of painkillers in a given year.

These conditions are among those for which medical marijuana is most often approved under state laws. Researchers ran a similar analysis on drug categories that pot typically is not recommended for – blood thinners, anti-viral drugs and antibiotics. And on those drugs, they found no changes in prescribing patterns after the passage of marijuana laws.

“This provides strong evidence that the observed shifts in prescribing patterns were in fact due to the passage of the medical marijuana laws,” they write.

In a news release, lead author Ashley Bradford wrote, “The results suggest people are really using marijuana as medicine and not just using it for recreational purposes.”

The tanking numbers for painkiller prescriptions in medical marijuana states are likely to cause some concern among pharmaceutical companies. These companies have long been at the forefront of opposition to marijuana laws, funding research by anti-pot academics and funneling dollars to groups, such as the Community Anti-Drug Coalitions of America, that oppose marijuana legalization.

In what may be the most concerning finding for the pharmaceutical industry, the Bradfords took their analysis a step further by estimating the cost savings to Medicare from the decreased prescribing. They found that about $165 million was saved in the 17 medical marijuana states in 2013. In a back-of-the-envelope calculation, the estimated annual Medicare prescription savings would be nearly half a billion dollars if all 50 states were to implement similar programs.

“That amount would have represented just under 0.5 percent of all Medicare Part D spending in 2013,” they calculate.

Cost-savings alone are not a sufficient justification for implementing a medical-marijuana program. The bottom line is better health, and the Bradfords’ research shows promising evidence that medical-marijuana users are finding plant-based relief for conditions that otherwise would have required a pill to treat.

“Our findings and existing clinical literature imply that patients respond to medical marijuana legislation as if there are clinical benefits to the drug, which adds to the growing body of evidence suggesting that the Schedule 1 status of marijuana is outdated,” the study concludes.

One limitation of the study is that it only looks at Medicare Part D spending, which applies only to seniors. Previous studies have shown that seniors are among the most reluctant medical-marijuana users, so the net effect of medical marijuana for all prescription patients may be even greater.

The Bradfords will next look at whether similar patterns hold for Medicaid.

DWC Reports on SB 863 Progress

The Department of Industrial Relations and its Division of Workers’ Compensation released their 2016 report on the progress in implementing Governor Brown’s 2012 workers’ compensation reforms. The report updates the efforts to improve benefits for injured workers while moderating rapidly increasing costs for employers.

“The primary goals of the 2012 workers’ compensation reforms were to increase benefits and improve medical care for injured workers, and to control costs for employers,” said Labor and Workforce Development Secretary David M. Lanier. “While significant progress toward meeting the goals sought by the Governor and the Legislature has been achieved, the department is pushing ahead to further reduce costs in the system by developing an evidence-based drug formulary and improved anti-fraud efforts.”

SB 863: Assessment of Workers’ Compensation Reforms is DIR’s third annual report since the law took effect on January 1, 2013. The changes in SB 863 (De León) include the use of evidence-based medicine to guide treatment decisions, treatment dispute settlements by independent medical reviewers, and improved workers’ access to network physicians. This year’s update includes:

1) Savings continue to be realized. Updated annual estimates of savings from reforms by the Workers’ Compensation Insurance Rating Bureau (WCIRB) are about $600 million greater than initially estimated. In May, the California Insurance Commissioner approved the advisory pure premium rates proposed by the WCIRB, rates that average $2.30 per $100 of payroll, effective July 1. These rates are, on average, 5 percent less than the industry average for filed pure premium rates as of January 1, 2016, and 10.4 percent less than the average of the approved January 1, 2016, advisory pure premium rates of $2.57.
2) Projected average medical costs per claim (excluding medical cost containment expenses) decreased by about 8 percent between 2011 and 2015.
3) Benefits for workers also improved. Permanent disability benefits to injured workers increased approximately 30 percent, and more than $41 million in Return to Work supplemental payments has been disbursed to eligible workers whose benefits are disproportionately low in comparison to their earnings losses.
4) A focus on evidence-based medicine has had wide-ranging impact, reducing costs and unnecessary treatment and creating an efficient Independent Medical Review (IMR) to resolve disputes. Further refinements are planned in this area.

Among SB 863’s goals was the implementation of evidence-based medicine guidelines for treatment decisions. Evidence of opioid abuse prompted legislation mandating the adoption of an evidence-based workers’ compensation drug formulary by July 1, 2017. DWC is engaged in efforts to promulgate regulations for a formulary, consistent with California’s Medical Treatment Utilization Schedule (MTUS), for medications prescribed in the workers’ compensation system. Other rulemaking is under way for home healthcare and interpreter services, and to extend the deadline for Return to Work supplement payments.

“Stakeholders have had valuable input at every stage in this process,” said DIR Director Christine Baker. “DIR looks forward to continuing our work with the stakeholders on these important reforms.”

DIR and DWC are also working to streamline the utilization review process, improve the MTUS to ensure it reflects current science and best practices, and exploring options for electronic submission of medical records to increase efficiency.

Starting this fall, DWC will launch an educational project to teach healthcare providers on the MTUS and the use of evidence-based medicine. This program will be available at no cost and will provide continuing medical educational credits for those who complete the course. Additional educational courses are planned beginning in the 4th quarter.

At the direction of Secretary Lanier, DIR is leading an effort to identify and address strategies for improved anti-fraud efforts in the workers’ compensation system. DIR and the Department of Insurance convened working groups in June to gather stakeholder input and evidence of fraudulent activity in the system, and the Department will be preparing a report on its policy recommendations to the Governor and the Legislature by no later than spring of 2017.

WCIRB Summarizes Past and Future Initiatives

In an open letter to the California workers’ compensation community WCIRB President and CEO Bill Mudge highlights some of the WCIRB’s key initiatives and accomplishments from the past year.

Through broad customer outreach, the WCIRB is actively collaborating to identify product opportunities and services that expand access to information and deliver new insights into the state of the system and its specific cost drivers. Its Senate Bill No. 863 WCIRB Cost Monitoring Report – 2015 Retrospective Evaluation revealed that total SB 863 savings are emerging greater than initially projected. Areas showing significant system-wide savings include reforms on liens and spinal implant surgeries, new fee schedules for physicians and ambulatory surgery centers, and reduced utilization of medical services. However, the Report also indicated that frictional costs, which were projected to decline with the SB 863 reforms, are increasing throughout California. The WCIRB will continue to monitor and annually report on the ongoing effects of SB 863.

The WCIRB has implemented significant enhancements to California’s Experience Rating Plan. including: Effective 2015, a limitation was added to restrict the impact of a single claim in the experience period to no more than 25 percentage points, reducing volatility in experience ratings for small experience rated employers.

Effective 2016, the basis of experience rating eligibility was shifted to expected loss rates (included as part of the WCIRB’s annual June regulatory filing) from pure premium rates (typically approved in November), in order to accelerate the timing of the WCIRB’s issuance of experience modifications to employers. With this shift, which was approved by the Insurance Commissioner, the WCIRB issued 80% of all January 2016 experience modifications more than 90 days prior to policy expiration (compared to 25% under the prior years’ approach based on approved pure premium rates).

Effective 2017, the Insurance Commissioner’s approved variable split point formula will be implemented. This significant change will vary the primary/excess loss split point based on an employer’s size (expected losses), reducing volatility for smaller employers, enhancing the actuarial performance of the Experience Rating Plan, and allowing for future simplification of the experience rating formula.

During 2015, the number of customer touch points with the WCIRB exceeded 2 million for the first time in company history. It expects to see continued growth in 2016 and beyond as additional online features are implemented, like a new coverage search capability for insurer claims adjusters that was launched in March 2016. New outreach efforts include ‘WCIRB Mod Talks’, a series of interactive webinars addressing the 2017 experience rating changes. The first webinar in this series garnered its highest customer attendance to date with over 300 online attendees and more than 150 viewing the recorded event.

Looking ahead, the WCIRB focused on several strategic, multi-year initiatives to further transform customers’ experience with the WCIRB. Among those on the horizon are:WCIRB CompEssentials(TM) – its online e-learning system designed to deliver flexible, on demand training for insurers, agents and brokers and other customer segments. CompEssentials will provide licensed agents and brokers with the opportunity to earn continuing education units.

Comprehensive Risk Summary Report (CRS) – designed to streamline workers’ compensation insurance by enabling authorized agents and brokers the ability to access consistent, objective, trusted WCIRB historical information and data on both experience rated and non-experience rated policyholders.

WCIRB Connect® – the WCIRB’s most widely used online service. With the future release of a ‘My Favorites’ customization, Connect users will be able to quickly access on one page the features and policyholder information they utilize most often.

In addition, the WCIRB continues to pursue the integration of external data sources with WCIRB data to identify new perspectives to enhance pure premium ratemaking and industry research, as well as shape ideas for potential new products and services in the years to come.

Buena Park Doctors’ License Revoked – Three Years After Fraud Conviction!

Way back in August 2013, a jury convicted a Buena Park physician of six counts of health care fraud for nearly $3 million in fraudulent claims to the Medicare system.

Dr. Augustus Ohemeng, 62, was convicted in federal court in Los Angeles after a five-day trial. He was among 10 defendants charged with operating a Medicare fraud ring. All 10 – including two doctors and a nurse – have been convicted, either by a jury or through guilty pleas.

The ring involved Pacific Clinic in Long Beach, where Ohemeng was medical director, as well as Ivy Medical Supply in Anaheim and Santos Medical Supply in south Los Angeles, prosecutors said. As medical director of Pacific Clinic, Ohemeng and others recruited patients and billed Medicare for unnecessary tests and procedures. According to prosecutors he generated fraudulent prescriptions for medical equipment, power wheelchairs and nutritional supplies. These prescriptions were then sold to medical supply companies that billed Medicare for millions of dollars of unnecessary and undelivered medical supplies.

He was sentenced to 3 1/2 years in prison. That is about the amount of time it took the California Medical Board to revoke his license.

On February 25, 2014, an Automatic Suspension Order – No Practice was issued. Then his certificate expired on April 30, 2014, and was in delinquent status while he was in prison.

On April 7, 2014, officials filed an Accusation seeking to discipline his license under Business and Professions Code sections 490, 2236 and 2236.1, based upon his felony conviction for health care fraud, and under section 2234 for unprofessional conduct, based upon the facts and circumstances resulting in this conviction.

On September 17, 2014, Ohemeng filed his Notice of Defense and request for hearing. He asked that any hearing not be conducted until at least 9 months after his release from the Half Way House custody of the Bureau of Prisons (‘BOP’).” Based on his anticipated release date, he requested that the hearing be scheduled “no earlier than June 1,2018.”

Despite his request, a hearing in his license revocation action convened before Administrative Law Judge Marilyn A. Woollard, Office of Administrative Hearings, State of California, in Sacramento, California, on February 1, 2016. Dr. Ohemeng, represented himself by telephone from Federal Prison South Camp, in Lompoc, California. In essence he argued that his health care fraud conviction is not substantially related to the qualifications, functions and duties of a physician.

In a written response he also stated that he “apologized to the courts and accepted “full responsibility for [his] actions” that resulted in his conviction. Respondent explained that he was brought up in a Christian home in Ghana, West Africa, where his father was a respected ordained Presbyterian Minister. Respondent was taught to “help those in need, especially underprivileged ones, and not to cheat or take advantage of these people. This kind of training in my childhood motivated me to go into medicine where I am able to help heal the sick and save lives which has been demonstrated throughout my years of practicing medicine since 1986 when I finished my training in Internal Medicine and Geriatric Medicine.”

In response to these arguments the ALJ ruled “Based on a review of the record as a whole and a review of the Manual of Model Disciplinary Orders and Disciplinary Guidelines, 11th Edition (2011) (Guidelines), revocation is the appropriate remedy.”

Appeals Court Delivers Another ObamaCare Law Blow

The workers’ compensation industry had mixed reactions to the passage of the Affordable Care Act a few years ago. Some believed it would be favorable to the industry by providing coverage for minor medical issues that might have ended up a comp claim had there been no other alternative solution for the patient. However, no matter what might have been the effect, as time goes by ObamaCare continues to suffer setbacks the cumulative effect threatens its very survival.

Earlier this month, the Court of Appeals for the D.C. Circuit issued its decision in Central United Life Insurance Co., v. Burwell, striking down a Department of Health and Human Services (HHS) rule prohibiting the sale and marketing of “fixed indemnity” plans to consumers who did not otherwise have minimum essential coverage. While at first pass the case focuses on a small set of insurance policies, this decision could have broader implications on the individual market and further threaten the sustainability of the risk pools.

This case focused on “fixed indemnity” policies, which are insurance products that pay out a fixed amount for each medical event, regardless of the actual cost of the service (e.g., the policy pays $100 per physician visit). Fixed indemnity policies are considered “excepted benefits” under the Public Health Service Act (PHSA), so long as (i) they are “provided under a spate policy, certificate, or contract of insurance,” and (ii) “are offered as independent non-coordinated benefits.” The Affordable Care Act (ACA) explicitly excluded excepted benefits from minimum essential coverage.

In 2014, HHS promulgated regulations which sought to make it more difficult for consumers to obtain these types of policies. The rules attempted to amend the criteria for when fixed indemnity policies could qualify as excepted benefits. Under the rule, HHS added a new criteria requiring that for fixed indemnity plans to qualify as an “excepted benefit” they can only be provided to individuals who already have minimum essential coverage. As the court noted, this would have effectively eliminated stand-alone fixed indemnity plans altogether.

Under a Chevron analysis, the court determined that HHS overstepped its authority, pointing out that HHS was attempting to amend the PHSA itself. Further, the court noted that Congress did not provide any leeway for HHS to “tack on” the additional criteria. The court rejected HHS’ argument that it has the authority to supplement the PHSA with reference to the Act’s requirement that the fixed indemnity plans must be “offered as independent, noncoordinated benefits.” During oral arguments the government also argued that this is a consumer protection measure and the rules are necessary and appropriate to carry out the insurance mandates of the ACA. The court did not address either argument in its brief opinion.

However, HHS’ argument that these rules are necessary and appropriate to carry out the ACA should not be discounted. Fixed indemnity policies appeal to the young and healthy – the exact population that is necessary to maintain sustainable risk pools and to keep premiums manageable. HHS sought to foreclose the option of offering fixed indemnity plans unless consumers otherwise had minimum essential coverage. With rising premiums in the individual market, having the option of fixed indemnity plans may tempt the young and healthy to select this type of coverage and incur tax penalty, rather than entering the individual market.

The Administration’s approach to this issue was intentional. If this population started using indemnity plans with greater frequency, it could create additional challenges to the ACA Marketplaces. Though the court ruled against the Administration, Congress can and is likely to consider legislative remedies if increased usage of indemnity plans causes deterioration of the ACA Marketplace.

WC Insurance Industry Returns to “Unsustainable” Profitability

After many years of underwriting losses, underwriting performance for the U.S. property/casualty (P/C) industry’s workers’ compensation line generated a significant profit in 2015, according to a new report from Fitch Ratings. Competition is heating up however and Fitch expects a return to an underwriting loss by 2017 in the workers’ compensation (P/C) line.

“The workers comp insurance market saw a sharp turnaround in the last few years due to past premium rate increases, stable loss cost trends and improved loss reserve experience, however, this performance will likely be unsustainable as price competition intensifies due in part to abundant market capacity,” said Jim Auden, Managing Director, Fitch.

The segment underwriting combined ratio dropped from a recent cyclical high of 117% in 2011 to 95% in 2015. Premium revenue growth tapered more recently, but averaged more than 5% for the last three years and was 3.5% in 2015. In the recent economic recession, workers’ compensation business suffered from weak pricing and significant declines in segment premium volume. The underwriting response to 2010 and 2011 losses, combined with improving economic conditions, led to a sharp increase in written premium volume for the segment.

Workers’ compensation is the largest individual product segment by premium volume in the commercial lines market and an important business line for a wide number of underwriters. Market share shifted significantly in workers’ compensation over the last five years. Prior industry leaders, American International Group, Inc. (AIG) and Liberty Mutual Insurance Group (Liberty Mutual) reduced premiums in the segment in response to past underwriting losses, while rapid growth was reported by several underwriters, particularly, Berkshire Hathaway Inc. and AmTrust Financial Services, Inc..

“As the market landscape shifts, there have been a number of companies that have demonstrated extraordinary growth, however, Fitch considers rapid growth that is well in excess of the market’s growth rate to add considerable risk to an insurer’s underwriting profile,” added Auden.

The full report ‘U.S. Workers’ Compensation Insurance Market Update’ is available at ‘www.fitchratings.com’.

Insurance Agent Faces Embezzlement Charges

Suren Hovhannisyan, 27, a licensed insurance agent of North Hollywood,was arrested at his residence on multiple felony counts of burglary, grand theft, and unauthorized use of access cards after allegedly scheming to embezzle over $100,000 from his employer and clients for his personal use.

After receiving a complaint from Hovhannisyan’s employer who suspected the embezzlement, the California Department of Insurance Investigation Division launched an investigation that revealed Hovhannisyan offered fictitious discounts to policyholders if they paid him in cash for their automobile insurance. Rather than remitting the cash payments to his employer, Hovhannisyan allegedly deposited the money into his mother’s bank account for his personal use.

A search warrant of Hovhannisyan’s residence also uncovered a notebook containing the names, Social Security numbers, and credit card numbers of dozens of other potential victims. Department investigators are working to identify and contact those victims.

Investigators found evidence that Hovhannisyan used the credit cards of some clients, without their permission, to pay the automobile insurance premiums of those who paid him with cash. One victim’s credit card was charged 145 times to pay a total of $45,545 in insurance premiums for 80 other policyholders.

The department is requesting that anyone who purchased insurance from Hovannisyan and provided cash payment, credit card or Social Security numbers to contact the department’s Investigation Division at (661) 253-7500.

Hovhannisyan was booked into Los Angeles County Jail. The Los Angeles District Attorney’s office is prosecuting this case. Hovhannisyan faces up to six years in prison, if convicted on all charges. The department has taken administrative action to suspend Hovhannisyan’s insurance license.

Filmmaker Sentenced for Manslaughter – Then Awarded Psyche Benefits?

Midnight Rider is an uncompleted American biographical drama film. Director Randall Miller co-wrote the screenplay with Jody Savin, based on the autobiography My Cross to Bear by the singer Gregg Allman. Miller and Savin were the producers.The film was to star William Hurt, Tyson Ritter, Zoey Deutch, Eliza Dushku, and Wyatt Russell.

On February 20, 2014, the first day of filming, the crew was on an active railroad trestle bridge, high over the Altamaha River in Wayne County, Georgia. Due to criminal negligence by the producers of the film, second camera assistant Sarah Jones was killed when she was struck by a CSX freight train that arrived on the trestle. Seven other crew members were also hurt, one seriously. Production was suspended the following week, and multiple investigations into the incident were undertaken. Miller, Savin, executive producer Jay Sedrish, and first assistant director Hillary Schwartz were charged with involuntary manslaughter and criminal trespass, as well as being cited by OSHA for “serious” and “willful” safety violations.

Miller and Sedrish entered guilty pleas to felony involuntary manslaughter and criminal trespassing, while charges were dropped against Savin as part of Miller’s plea. Miller received a sentence of ten years, of which he was expected to serve two years in jail followed by probation  On March 10, 2015 Schwartz pleaded guilty to felony involuntary manslaughter and criminal trespass, and was also sentenced to 10 years probation.

Hillary Schwartz also filed a workers’ compensation claim and alleged a psychiatric industrial injury as a result of this incident. Last December a Finding and Award found that she sustained an industrial injury to her psyche on February 20, 2014, while employed as a first assistant director, finding against defendant’s affirmative defense under Labor Code section 3600(a)(8) which precludes awarding benefits where injuries were caused by the commission of a felony. Schwartz was awarded temporary disability and further medical treatment, and all other issues were deferred.

The Defendant’s petition for reconsideration was denied in the split panel decision of Schwartz v Ease Entertainment. A Petition for Writ of Review has been filed with the Court of Appeal case number B271708. The Court has not yet acted on the Petition filed last April.

Evidence at the workers’ compensation trial showed that Schwartz accepted a plea agreement under the Georgia First Offender Act whereby she would be found guilty of the charges and would be placed on probation for ten years. Upon the successful completion of her probation, there would be no entry of judgment and no adjudication of guilt.

Pursuant to this agreement, a Bench Trial in the criminal case was held on March 10, 2015, in the Superior Court of Wayne County, State of Georgia. After reviewing the evidence the trial Judge said I “find you guilty in Count of criminal trespass and guilty in Count 5 of involuntary manslaughter.” The Judge approved applicant’s “First Offender Petition,” which states that the Court entered a verdict of guilty to the offenses and that “no judgment has been entered and no adjudication of guilt has been made.” The Petition further states: “Defendant hereby consents to the Court’s withholding the entry of a judgment of guilt, deferring adjudication, and deferring further proceedings, placing her on probation as provided by O.C.G.A. §42-8-60.”

As a result the WCJ concluded that under a strict interpretation of the language of section 3600(a)(8), a conviction is required to bar a claim for workers’ compensation benefits. In view of the deferral of applicant’s prosecution after a finding of guilt by the Court, the WCJ concluded that the requirement that applicant’s injury be caused by the commission of a felony for which she was “convicted” has not been met. The WCAB agreed with this reasoning and denied reconsideration of the Award. Essentially both reasoned that technically there was no “judgment” of a felony as required by the Labor Code should she successfully complete the terms of her probation under the First Offender Law.

Commissioner Razo dissented. He reasoned that “as a consequence of applicant’s conduct, she was determined by a Superior Court Judge to have committed acts which constitute a felony. The Judge found applicant guilty of criminal trespass and involuntary manslaughter in the death of Sarah Jones. This finding constitutes applicant’s conviction of a felony, which under Labor Code section 3600(a)(8), bars her claim for workers’ compensation benefits for an injury to her psyche arising out of her felonious conduct. That applicant was subsequently accorded leniency in her sentencing does not obviate the fact that she was found guilty of involuntary manslaughter. I would therefore grant defendant’s Petition for Reconsideration and find applicant’s claim is barred.”

Declining Major Disease Rates May Complicate Reserving Estimates

Something strange is going on in medicine. Major diseases, like colon cancer, dementia and heart disease, are waning in wealthy countries, and improved diagnosis and treatment cannot fully explain it. And this news will certainly complicate the process of reserving for a lifetime medical award.

According to the report in the New York Times, scientists marvel at this good news, a medical mystery of the best sort and one that is often overlooked as advocacy groups emphasize the toll of diseases and the need for more funds. Still, many are puzzled.

Of course, these diseases are far from gone. They still cause enormous suffering and kill millions each year. But it looks as if people in the United States and some other wealthy countries are, unexpectedly, starting to beat back the diseases of aging. The leading killers are still the leading killers – cancer, heart disease, stroke – but they are occurring later in life, and people in general are living longer in good health.

Colon cancer is the latest conundrum. While the overall cancer death rate has been declining since the early 1990s, the plunge in colon cancer deaths is especially perplexing: The rate has fallen by nearly 50 percent since its peak in the 1980s, noted Dr. H. Gilbert Welch and Dr. Douglas J. Robertson of the Geisel School of Medicine at Dartmouth and the Veterans Affairs Medical Center in White River Junction, Vt., in a recent paper.

Screening, they say, is only part of the story. “The magnitude of the changes alone suggests that other factors must be involved,” they wrote. None of the studies showing the effect of increased screening for colon cancer have indicated a 50 percent reduction in mortality, they wrote, ‘nor have trials for screening for any type of cancer.’

Then there are hip fractures, whose rates have been dropping by 15 to 20 percent a decade over the past 30 years. Although the change occurred when there were drugs to slow bone loss in people with osteoporosis, too few patients took them to account for the effect – for instance, fewer than 10 percent of women over 65 take the drugs.

Dementia rates, too, have been plunging. It took a few reports and more than a decade before many people believed it, but data from the United States and Europe are becoming hard to wave off. The latest report finds a 20 percent decline in dementia incidence per decade, starting in 1977.

A recent American study, for example, reports that the incidence among people over age 60 was 3.6 per 100 in the years 1986-1991, but in the years 2004-2008 it had fallen to 2.0 per 100 over age 60. With more older people in the population every year, there may be more cases in total, but an individual’s chance of getting dementia has gotten lower and lower.

The exemplar for declining rates is heart disease. Its death rate has been falling for so long – more than half a century – that it’s no longer news. The news now is that the rate of decline seems to have slowed recently, although it is still falling. While heart disease is still the leading cause of death in the United States, killing more than 300,000 people a year, deaths have fallen 60 percent from their peak. The usual suspects: Better treatment, better prevention with drugs like statins and drugs for blood pressure, and less smoking, are, of course, helping drive the trend. But they are not enough, heart researchers say, to account fully for the decades-long decline.

Purdue Pharma Silent as Oxycontin Rings Explode in LA

The Los Angeles Times reported on its stunning investigation of L.A. Oxycontin rings that distributed millions of dollars of opiates, all with the knowledge and apparent silent approval of drugmakers such as Purdue Pharma.

In 2008, a convicted felon and his business partner leased office space on a seedy block near MacArthur Park. They set up a waiting room, hired an elderly physician, Eleanor Santiago M.D., and gave the place a name that sounded like an ordinary clinic: Lake Medical. The doctor began prescribing the opioid painkiller OxyContin – in extraordinary quantities. In a single week in September 2008, Santiago issued orders for 1,500 pills, more than entire pharmacies sold in a month. In October, it was 11,000 pills. By December, she had prescribed more than 73,000, with a street value of nearly $6 million.

To keep the OxyContin flowing, Lake Medical needed people whose time was cheap. For that, there was no place better than skid row. For as little as $25, homeless people served as straw patients and collected prescriptions for “80s”, 80-milligram pills with the strength of 16 Vicodin tablets and very popular on the streets. It required just a few hours at the clinic, then they were driven, often in groups, to a pharmacy, where a capper acting as a chaperone paid the bill in cash. He then took the pills back to the Lake Medical ring leaders who packaged them in bulk for sale to drug dealers.

A physician writing a high volume of “80s” was a red flag for anyone trying to detect how OxyContin was getting into the black market. The number of prescriptions Santiago was writing wasn’t merely high. It was jaw-dropping. Many doctors would go their entire careers without writing a single “80s” prescription. Santiago doled out 26 in a day.

Purdue Pharma, the maker of OxyContin, tracked the surge in prescriptions. A sales manager went to check out the clinic and the company launched an investigation. It eventually concluded that Lake Medical was working with a corrupt pharmacy in Huntington Park to obtain large quantities of OxyContin. Yet Purdue did not shut off the supply of highly addictive OxyContin and did not tell authorities what it knew about Lake Medical until several years later when the clinic was out of business and its leaders indicted. By that time, 1.1 million pills had spilled into the hands of mobsters, the Crips gang and other criminals. The pills from Lake Medical coursed out of L.A. An informant would later tell an FBI agent that East Hollywood’s White Fence gang trafficked pills to Chicago.

Legitimate pharmacists from La Canada-Flintridge, Glendale, Moreno Valley and elsewhere complained to Purdue. Company executives and lawyers received at least 11 reports about Santiago in the four months after they first suspected her. For example, on June 10, an Encino pharmacist sent an email to her Purdue sales rep with the subject line “urgent question.” The pharmacist said she was being asked to fill prescriptions written by Santiago and other Lake Medical doctors for “lots of Oxy patients.” “I want to make sure Dr office is legit,” Tihana Skaricic wrote. “So wondering….if you know ‘behind the scenes.” No one at Purdue ever got back to Skaricic. Eventually she and some other pharmacists decided on their own to turn away business from Lake Medical.

And the Los Angeles Times investigation found that, for more than a decade, Purdue collected extensive evidence suggesting illegal trafficking of OxyContin and, in many cases, did not share it with law enforcement or cut off the flow of pills. A former Purdue executive, who monitored pharmacies for criminal activity, acknowledged that even when the company had evidence pharmacies were colluding with drug dealers, it did not stop supplying distributors selling to those stores. Purdue knew about many suspicious doctors and pharmacies from prescribing records, pharmacy orders, field reports from sales representatives and, in some instances, its own surveillance operations.

Purdue had access to a stream of data showing how individual doctors across the nation were prescribing OxyContin. The information came from IMS Health, a company that buys prescription data from pharmacies and resells it to drugmakers for marketing purposes. That information was vital to Purdue’s sales department. Representatives working on commission used it to identify doctors writing a small number of OxyContin prescriptions who might be persuaded to write more. By combing through the data, Purdue also could identify physicians writing large numbers of prescriptions – a potential sign of drug dealing.

And the data at its fingertips was astounding. At one San Marino store, Huntington Pharmacy, monthly orders for “80s” were up nearly 20-fold over the previous year. At another in East L.A., orders jumped 400% in two months. A small shop in Panorama City, Mission Pharmacy, became the top seller of OxyContin in the entire state of California. Mission was a top supplier to the Lake Medical ring In Southern California there was a troubling spike in sales at St. Paul’s Pharmacy in Huntington Park from filling prescriptions for Lake Medical. Purdue added those store names to a long list of problematic pharmacies across the country.

A private, family-owned corporation, Purdue has earned more than $31 billion from OxyContin, the nation’s bestselling painkiller. A year before Lake Medical opened, Purdue and three of its executives pleaded guilty to federal charges of misbranding OxyContin in what the company acknowledged was an attempt to mislead doctors about the risk of addiction. It was ordered to pay $635 million in fines and fees.

In the end, the Lake Medical ring was brought down by a team of state, federal and local investigators who collected tips from citizens and spent hours staking out the clinic, interviewing witnesses and turning junior ring members into informants. When Lake Medical closed in 2010, after a year and a half in business, Purdue had still not shared its wealth of information on the clinic with the authorities, according to law enforcement sources.